Search Result
Results for "
DPPE
" in MedChemExpress (MCE) Product Catalog:
51
Biochemical Assay Reagents
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-144012
-
|
16:0 PEG2000 PE ammonium; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Liposome
|
Others
|
|
DPPE-PEG2000 ammonium (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG2000 ammonium enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG2000 ammonium helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG2000 ammonium serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
-
- HY-144012H
-
|
16:0 PEG5000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Liposome
|
Others
|
|
DPPE-PEG5000 (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG5000 enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG5000 helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG5000 serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
-
- HY-172340
-
-
-
- HY-144012A
-
|
16:0 PEG350 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Liposome
CD1
|
Others
|
|
DPPE-PEG350 is a CD1d-dependent lipid antagonist thus blocking the ERK phosphorylation pathway in iNKT cells . DPPE-PEG350 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles.
|
-
-
- HY-165156
-
|
1,2-DPPE-MPEG(2000)
|
Liposome
|
Others
|
|
DPPE-MPEG 2000 (1,2-DPPE-MPEG(2000)) is a PEG-modified lipids. DPPE-MPEG 2000 can reduce the nonspecific adsorption of protein and prolong circulation time in vivo .
|
-
-
- HY-101179
-
-
-
- HY-W343736
-
|
1,3-DPPE; 1,3-Dipalmitoyl-sn-glycero-2-PE
|
Liposome
|
Cancer
|
|
1,3-Dipalmitoyl-glycero-2-phosphoethanolamine is a phospholipid containing the saturated long-chain (16:0) stearic acid inserted at the sn-1 and sn-3 positions and PE at the sn-2 site. It can be used in the generation of micelles, liposomes, and other types of artificial membranes.
|
-
-
- HY-144012B
-
|
16:0 PEG550 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
|
DPPE-PEG550 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144012E
-
|
16:0 PEG3000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
|
DPPE-PEG3000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144012D
-
|
16:0 PEG1000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
|
DPPE-PEG1000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144012C
-
|
16:0 PEG750 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
|
DPPE-PEG750 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-W800794
-
|
DPPE-NG; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(glutaryl)
|
Liposome
|
Cancer
|
|
16:0 Glutaryl PE is is a carboxylic acid-functionalized lipid with a three carbon linker to a phosphoethanolamine bound to two palmitic acid tails.
|
-
-
- HY-174946
-
|
DPPE-PEG1-N3
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1-azide (DPPE-PEG1-N3) is a PEG-modified lipid containing an azide group. DPPE-PEG1-azide can undergo a copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing an alkynyl group. It can also undergo ring strain-driven alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups .
|
-
-
- HY-174946A
-
|
DPPE-PEG5-N3
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5-azide (DPPE-PEG5-N3) is a PEG-modified lipid containing an azide group. DPPE-PEG5-azide can undergo a copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing an alkynyl group. It can also undergo ring strain-driven alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups .
|
-
-
- HY-166980
-
|
|
Biochemical Assay Reagents
|
Others
|
|
m-PEG-DPPE (MW 2000) is a PEG lipid that can improve the delivery efficiency and tissue specificity of poorly soluble drugs. m-PEG-DPPE (MW 2000) can be used in drug delivery research .
|
-
-
- HY-166644
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-amine is a phospholipid. Phospholipids have good biocompatibility and significant amphiphilic characteristics, making them the main and suitable dosage form or excipient in drug formulations, thereby achieving better therapeutic effects. DPPE-PEG2000-aminecan be used in drug delivery research .
|
-
-
- HY-174972A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG-DPPE (MW 5000) is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
-
- HY-174947
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2-mal is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
-
- HY-101179R
-
-
-
- HY-157974
-
|
|
Paraptosis
|
Cancer
|
|
[Ag(2,2′-bipy)(dppe)][CF3SO3] (compound 4) can induce cell paraptosis, and can be used for stusy of resistant ovarian cancer .
|
-
-
- HY-174972E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG750-DPPE is a PEGylated phospholipid containing DPPE. mPEG750-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972J
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DPPE is a PEGylated phospholipid containing DPPE. mPEG30000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG500-DPPE is a PEGylated phospholipid containing DPPE. mPEG500-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972H
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DPPE is a PEGylated phospholipid containing DPPE. mPEG10000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG350-DPPE is a PEGylated phospholipid containing DPPE. mPEG350-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-174972D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG550-DPPE is a PEGylated phospholipid containing DPPE. mPEG550-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-182882C
-
|
DPPE-PEG5000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-SH (DPPE-PEG5000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG5000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
-
- HY-182882
-
|
DPPE-PEG1000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-SH (DPPE-PEG1000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG1000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
-
- HY-182882A
-
|
DPPE-PEG2000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-SH (DPPE-PEG2000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG2000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
-
- HY-182882D
-
|
DPPE-PEG10000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-SH (DPPE-PEG10000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG10000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
-
- HY-182882B
-
|
DPPE-PEG3400-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-SH (DPPE-PEG3400-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG3400-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052051A
-
|
DPPE-PEG3400-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-N3 (DPPE-PEG3400-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052051B
-
|
DPPE-PEG5000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-N3 (DPPE-PEG5000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052051
-
|
DPPE-PEG2000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-N3 (DPPE-PEG2000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052051D
-
|
DPPE-PEG1000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-N3 (DPPE-PEG1000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052051C
-
|
DPPE-PEG10000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-N3 (DPPE-PEG10000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-174972I
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DPPE is a PEGylated phospholipid containing DPPE. DOPE-mPEG750 combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-172341
-
|
|
Biochemical Assay Reagents
|
Others
|
|
N-Palmitoyl-DPPE (triethylammonium) is a N-acylphosphatidylethanolamine (NAPE) lipid. N-Palmitoyl-DPPE (triethylammonium) is a palmitic acid derivative of dipalmitoylphosphatidylethanolamine (DPPE) .
|
-
-
- HY-W1052873C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052873
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052873D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052873B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052873A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052492
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG2000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052492B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG5000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052492A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG3400-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052492C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-W1052492D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG10000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
-
- HY-179837
-
|
|
Liposome
|
Metabolic Disease
|
|
DPPE-mPEG sodium is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.
|
-
-
- HY-W1052523C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG1000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG3400-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG2000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG10000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG5000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052697
-
|
|
Liposome
|
Metabolic Disease
|
|
(R)-DPPE-mPEG(2000) is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.
|
-
- HY-182833A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG10000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG3400-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG1000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG5000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-174972
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG-DPPE (MW 1000) is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-176028
-
|
NAPE(16:0/16:0/18:0); N-Stearoyl-1,3-dipalmitoyl-3-PE
|
Drug Intermediate
|
Inflammation/Immunology
|
|
N-Stearoyl-DPPE ammonium is a type of N-acylphosphatidylethanolamine (NAPE). N-Stearoyl-DPPE ammonium is an important intermediate in the endocannabinoid biosynthesis pathway .
|
-
- HY-176029
-
|
NAPE(16:0/16:0/18:1); N-Oleoyl-1,2-dipalmitoyl-3-PE
|
Drug Intermediate
|
Neurological Disease
Inflammation/Immunology
|
|
N-Oleoyl-DPPE ammonium is an N-acylphosphatidylethanolamine (NAPE). N-Oleoyl-DPPE ammonium is a biosynthetic precursor of oleoylethanolamide (OEA), an endocannabinoid derivative and peroxisome proliferator-activated receptor α (PPARα) agonist. N-Oleoyl-DPPE ammonium can be used in the study of neuroinflammation and alcohol abuse .
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-144012
-
|
16:0 PEG2000 PE ammonium; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000 ammonium (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG2000 ammonium enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG2000 ammonium helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG2000 ammonium serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
- HY-144012H
-
|
16:0 PEG5000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000 (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG5000 enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG5000 helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG5000 serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
- HY-144012A
-
|
16:0 PEG350 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG350 is a CD1d-dependent lipid antagonist thus blocking the ERK phosphorylation pathway in iNKT cells . DPPE-PEG350 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles.
|
-
- HY-144012B
-
|
16:0 PEG550 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG550 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012E
-
|
16:0 PEG3000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG3000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012D
-
|
16:0 PEG1000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012C
-
|
16:0 PEG750 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG750 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-174946
-
|
DPPE-PEG1-N3
|
Biochemical Assay Reagents
|
|
DPPE-PEG1-azide (DPPE-PEG1-N3) is a PEG-modified lipid containing an azide group. DPPE-PEG1-azide can undergo a copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing an alkynyl group. It can also undergo ring strain-driven alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups .
|
-
- HY-174946A
-
|
DPPE-PEG5-N3
|
Biochemical Assay Reagents
|
|
DPPE-PEG5-azide (DPPE-PEG5-N3) is a PEG-modified lipid containing an azide group. DPPE-PEG5-azide can undergo a copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing an alkynyl group. It can also undergo ring strain-driven alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups .
|
-
- HY-166980
-
|
|
Biochemical Assay Reagents
|
|
m-PEG-DPPE (MW 2000) is a PEG lipid that can improve the delivery efficiency and tissue specificity of poorly soluble drugs. m-PEG-DPPE (MW 2000) can be used in drug delivery research .
|
-
- HY-166644
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-amine is a phospholipid. Phospholipids have good biocompatibility and significant amphiphilic characteristics, making them the main and suitable dosage form or excipient in drug formulations, thereby achieving better therapeutic effects. DPPE-PEG2000-aminecan be used in drug delivery research .
|
-
- HY-174972A
-
|
|
Biochemical Assay Reagents
|
|
mPEG-DPPE (MW 5000) is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-174947
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2-mal is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
-
- HY-174972E
-
|
|
Biochemical Assay Reagents
|
|
mPEG750-DPPE is a PEGylated phospholipid containing DPPE. mPEG750-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972J
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DPPE is a PEGylated phospholipid containing DPPE. mPEG30000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972C
-
|
|
Biochemical Assay Reagents
|
|
mPEG500-DPPE is a PEGylated phospholipid containing DPPE. mPEG500-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972H
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DPPE is a PEGylated phospholipid containing DPPE. mPEG10000-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972B
-
|
|
Biochemical Assay Reagents
|
|
mPEG350-DPPE is a PEGylated phospholipid containing DPPE. mPEG350-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-174972D
-
|
|
Biochemical Assay Reagents
|
|
mPEG550-DPPE is a PEGylated phospholipid containing DPPE. mPEG550-DPPE combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-182882C
-
|
DPPE-PEG5000-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-SH (DPPE-PEG5000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG5000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182882
-
|
DPPE-PEG1000-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-SH (DPPE-PEG1000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG1000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182882A
-
|
DPPE-PEG2000-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-SH (DPPE-PEG2000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG2000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182882D
-
|
DPPE-PEG10000-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-SH (DPPE-PEG10000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG10000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182882B
-
|
DPPE-PEG3400-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-SH (DPPE-PEG3400-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG3400-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051A
-
|
DPPE-PEG3400-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-N3 (DPPE-PEG3400-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051B
-
|
DPPE-PEG5000-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-N3 (DPPE-PEG5000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051
-
|
DPPE-PEG2000-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-N3 (DPPE-PEG2000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051D
-
|
DPPE-PEG1000-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-N3 (DPPE-PEG1000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051C
-
|
DPPE-PEG10000-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-N3 (DPPE-PEG10000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-174972I
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DPPE is a PEGylated phospholipid containing DPPE. DOPE-mPEG750 combines the membrane fusion capability of DPPE with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052873C
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052873
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052873D
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052873B
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052873A
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052492
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG2000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052492B
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG5000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052492A
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG3400-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052492C
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052492D
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG10000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523C
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG1000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523A
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG3400-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG2000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523D
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG10000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523B
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG5000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-182833A
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833D
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG10000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833B
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG3400-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG1000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833C
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG5000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-174972
-
|
|
Biochemical Assay Reagents
|
|
mPEG-DPPE (MW 1000) is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications .
|
| Cat. No. |
Product Name |
|
Classification |
-
- HY-W1052051A
-
|
DPPE-PEG3400-Azide
|
|
Azide
|
|
DPPE-PEG3400-N3 (DPPE-PEG3400-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051B
-
|
DPPE-PEG5000-Azide
|
|
Azide
|
|
DPPE-PEG5000-N3 (DPPE-PEG5000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051
-
|
DPPE-PEG2000-Azide
|
|
Azide
|
|
DPPE-PEG2000-N3 (DPPE-PEG2000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051D
-
|
DPPE-PEG1000-Azide
|
|
Azide
|
|
DPPE-PEG1000-N3 (DPPE-PEG1000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051C
-
|
DPPE-PEG10000-Azide
|
|
Azide
|
|
DPPE-PEG10000-N3 (DPPE-PEG10000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
| Cat. No. |
Product Name |
|
Classification |
-
- HY-144012
-
|
16:0 PEG2000 PE ammonium; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG2000 ammonium (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG2000 ammonium enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG2000 ammonium helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG2000 ammonium serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
- HY-144012H
-
|
16:0 PEG5000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG5000 (16:0 PEG5000 PE) is a polymer-lipid conjugate and LipoParticle stabilizer with a PEG chain of 5,000 g/mol molecular weight attached to its polar head, and it can be internalized by biological membranes. DPPE-PEG5000 enables LipoParticle to maintain colloidal stability after 20-fold dilution in PBS or cell culture medium, and prevents aggregate formation during lyophilization and rehydration. DPPE-PEG5000 helps enhance the non-cytotoxic property of LipoParticle formulations against human osteoblasts. DPPE-PEG5000 serves as a PEG lipid functional end group for synthesizing liposomes (LPs), is used in the design of conjugated polymer nanoparticles, and applies to research related to bone and joint infections .
|
-
- HY-144012A
-
|
16:0 PEG350 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG350 is a CD1d-dependent lipid antagonist thus blocking the ERK phosphorylation pathway in iNKT cells . DPPE-PEG350 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles.
|
-
- HY-165156
-
|
1,2-DPPE-MPEG(2000)
|
|
Pegylated Lipids
|
|
DPPE-MPEG 2000 (1,2-DPPE-MPEG(2000)) is a PEG-modified lipids. DPPE-MPEG 2000 can reduce the nonspecific adsorption of protein and prolong circulation time in vivo .
|
-
- HY-W343736
-
|
1,3-DPPE; 1,3-Dipalmitoyl-sn-glycero-2-PE
|
|
Phospholipids
|
|
1,3-Dipalmitoyl-glycero-2-phosphoethanolamine is a phospholipid containing the saturated long-chain (16:0) stearic acid inserted at the sn-1 and sn-3 positions and PE at the sn-2 site. It can be used in the generation of micelles, liposomes, and other types of artificial membranes.
|
-
- HY-144012B
-
|
16:0 PEG550 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG550 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012E
-
|
16:0 PEG3000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG3000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012D
-
|
16:0 PEG1000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG1000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012C
-
|
16:0 PEG750 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG750 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-W800794
-
|
DPPE-NG; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(glutaryl)
|
|
Phospholipids
|
|
16:0 Glutaryl PE is is a carboxylic acid-functionalized lipid with a three carbon linker to a phosphoethanolamine bound to two palmitic acid tails.
|
-
- HY-166980
-
|
|
|
Pegylated Lipids
|
|
m-PEG-DPPE (MW 2000) is a PEG lipid that can improve the delivery efficiency and tissue specificity of poorly soluble drugs. m-PEG-DPPE (MW 2000) can be used in drug delivery research .
|
-
- HY-166644
-
|
|
|
Pegylated Lipids
|
|
DPPE-PEG2000-amine is a phospholipid. Phospholipids have good biocompatibility and significant amphiphilic characteristics, making them the main and suitable dosage form or excipient in drug formulations, thereby achieving better therapeutic effects. DPPE-PEG2000-aminecan be used in drug delivery research .
|
-
- HY-179837
-
|
|
|
Pegylated Lipids
|
|
DPPE-mPEG sodium is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.
|
-
- HY-W1052697
-
|
|
|
Pegylated Lipids
|
|
(R)-DPPE-mPEG(2000) is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: